CN1435217A - Bone-strengthening medicine and producing method thereof - Google Patents
Bone-strengthening medicine and producing method thereof Download PDFInfo
- Publication number
- CN1435217A CN1435217A CN 02130993 CN02130993A CN1435217A CN 1435217 A CN1435217 A CN 1435217A CN 02130993 CN02130993 CN 02130993 CN 02130993 A CN02130993 A CN 02130993A CN 1435217 A CN1435217 A CN 1435217A
- Authority
- CN
- China
- Prior art keywords
- radix
- processed
- draconis
- myrrha
- olibanum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of capsule for treating femur head necrosis is prepared from 9 Chinese-medicinal materials including Chinese angelica root, notoginseng, earthworm, myrrh, etc through washing, drying, proportional mixing, grinding by 100 meshes, and capsulizing. Its advantages are high curative effect and low cost.
Description
Technical field
The invention belongs to the Chinese medicine technical field, particularly relate to a kind of bone strengthening medicine for the treatment of femur head necrosis.
Background technology
Femur head necrosis is a kind of stubborn disease, and the serious harm people are healthy, and it can occur in all ages and classes stage, especially with young and middle-aged and old in the majority, its clinical manifestation mainly contains pain, common sympton such as handicapped, can't take care of oneself when serious, must the displacement hip.
Numerous for many years medical science scholars and expert, though this treatment of diseases method has been done number of research projects, up to the present, still there are many drawbacks in existing therapeutic method of traditional Chinese and western medicine.As doctor trained in Western medicine operating substitution femoral head, about 10 years longest-lived time, and cost an arm and a leg.The traditional Chinese medical science generally adopts the decoction treatment by Chinese herbs, and this not only can make the patient take decoction for a long time, and therapeutic effect is also undesirable.
Summary of the invention
The technical issues that need to address of the present invention are: a kind of bone strengthening medicine is provided, its treatment femur head necrosis satisfactory for result, cheap and need not the operation.
Technical solution of the present invention is: a kind of bone strengthening medicine, form by following compatibility of drugs:
Radix Angelicae Sinensis 3～8% Olibanum (processed) 2～8% Radix Achyranthis Bidentataes 2～8%
Radix Notoginseng 2～7% Cortexs Eucommiae 1～5% Radix Rehmanniae Preparata 2～6%
Concha Ostreae 2～8% Pheretimas 1～5% Myrrha (processed) 2～8%
Moschus 0.5～1% Radix Dipsaci 2～6% catechu 1～5%
The Radix Polygoni Multiflori 2～6% Rhizoma Dioscoreaes 2～8% Squama Manis 2～10%
Radix Angelicae Pubescentis 1～6% Stigma Croci 3～10% Os Draconis 2～8%
Rhizoma Chuanxiong 2～8% Fructus Lyciis 2～8% Radix Clematidis 2～8%
Eupolyphage sece steleophaga 5～15% drynaria baroniis 2～8% Borneolum Syntheticums 0.2～1%
Sanguis Draxonis 2～6% Agkistrodons 1～4%
A kind of manufacture method of bone strengthening medicine is: Radix Angelicae Sinensis, Olibanum (processed), Radix Achyranthis Bidentatae, Radix Notoginseng, the Cortex Eucommiae, Radix Rehmanniae Preparata, Concha Ostreae, Pheretima, Myrrha (processed), Moschus, Radix Dipsaci, catechu, the Radix Polygoni Multiflori, Rhizoma Dioscoreae, Squama Manis, Radix Angelicae Pubescentis, Stigma Croci, Os Draconis, Rhizoma Chuanxiong, Fructus Lycii, Radix Clematidis, eupolyphage sece steleophaga, drynaria baronii, Borneolum Syntheticum, Sanguis Draxonis, this group of Agkistrodon medicine is selected first-class medical material meticulously, decontamination, clear water is cleaned, dry for standby, Radix Angelicae Sinensis wine is fried, Olibanum, Myrrha deoils, Os Draconis, the Concha Ostreae fire is forged, drynaria baronii, the Cortex Eucommiae, Squama Manis is concocted, Radix Achyranthis Bidentatae, Radix Dipsaci, Radix Clematidis, the Radix Polygoni Multiflori is gently fried, and the Radix Rehmanniae Preparata oven dry adds other drug, wears into smalls (100 order), stir, make capsule.
The present invention compared with prior art has following advantage: the first phase necrosis, take a month sx, and pain is eliminated substantially, and it is convenient to walk.Second phase is downright bad, take one month after, pain relief, after two months, walking freely can be gone up downstairs.The necrosis of three phases serve on 3 months sxs, serve on half a year, functional rehabilitation health.The present invention has no adverse reaction and toxic and side effects, and is satisfactory for result, cheap and need not the operation.
Specific embodiments
Theory of Chinese medical science is thought: femur head necrosis is main and blockage of main and collateral channels, blood fortune deficiency, kidney qi loss, femoral head are withered, Chinese traditional treatment develops pathological changes with invigorating the kidney and strengthening the bones, dredge the meridian passage, strengthening vital QI to eliminate pathogenic factors, control femoral head.Theory of Chinese medical science is thought prolonged illness people network, the prolonged illness blood stasis, for a long time the stasis of blood then then obstructed, the damp and hot pent-up of numbness, numbness injure that venation, pain are then obstructed, general rule not bitterly.The kidney being the origin of congenital constitution, kidney governing bones, and main the dominator of storing essence, smart part is also.Kidney is subjected to the essence of five ZANG-organs and six FU-organs and hides it.It is not solid that deficiency of the kidney is then sealed the Tibetan, can not collect the essence of five ZANG-organs and six FU-organs gas, and then vital essence deficiency, meridians lose and support, and finally form femur head necrosis.
Modern medicine thinks, femur head necrosis pathology changes, and shows mainly that blood supply insufficiency, hormonal medicaments use in a large number, excessive drinking, wound, thereby femur head necrosis takes place.
Provide the formulation ratio of the compound Chinese medicinal preparation of treatment femur head necrosis below, adjustable extent (proportioning employing percentage by weight)
Bone strengthening medicine medicine of the present invention is formed by following feedstock production:
Radix Angelicae Sinensis 3～8% Olibanum (processed) 2～8% Radix Achyranthis Bidentataes 2～8%
Radix Notoginseng 2～7% Cortexs Eucommiae 1～5% Radix Rehmanniae Preparata 2～6%
Concha Ostreae 2～8% Pheretimas 1～5% Myrrha (processed) 2～8%
Moschus 0.5～1% Radix Dipsaci 2～6% catechu 1～5%
The Radix Polygoni Multiflori 2～6% Rhizoma Dioscoreaes 2～8% Squama Manis 2～10%
Radix Angelicae Pubescentis 1～6% Stigma Croci 3～10% Os Draconis 2～8%
Rhizoma Chuanxiong 2～8% Fructus Lyciis 2～8% Radix Clematidis 2～8%
Eupolyphage sece steleophaga 5～15% drynaria baroniis 2～8% Borneolum Syntheticums 0.2～1%
Sanguis Draxonis 2～6% Agkistrodons 1～4%
The preferred weight ratio of each percentage composition of above-mentioned raw materials is:
Radix Angelicae Sinensis 4.6% Olibanum (processed) 4% Radix Achyranthis Bidentatae 4%
Radix Notoginseng 4% Cortex Eucommiae 3.6% Radix Rehmanniae Preparata 4.3%
Concha Ostreae 4.3% Pheretima 2.8% Myrrha (processed) 4%
Moschus 0.7% Radix Dipsaci 4% catechu 2.8%
The Radix Polygoni Multiflori 4.3% Rhizoma Dioscoreae 3.6% Squama Manis 4%
Radix Angelicae Pubescentis 2.9% Stigma Croci 5.7% Os Draconis 4.3%
Rhizoma Chuanxiong 4% Fructus Lycii 3.6% Radix Clematidis 4.3%
Eupolyphage sece steleophaga 10% drynaria baronii 4% Borneolum Syntheticum 0.5%
Sanguis Draxonis 4.3% Agkistrodon 1.4%
Medicine of the present invention can be made pharmaceutical dosage form commonly used according to the formulation method of routine, as tablet, pill, capsule, powder etc.
The preparation method of medicine capsule of the present invention is with Radix Angelicae Sinensis, Olibanum (processed), Radix Achyranthis Bidentatae, Radix Notoginseng, the Cortex Eucommiae, Radix Rehmanniae Preparata, Concha Ostreae, Pheretima, Myrrha (processed), Moschus, Radix Dipsaci, catechu, the Radix Polygoni Multiflori, Rhizoma Dioscoreae, Squama Manis, Radix Angelicae Pubescentis, two Flos Carthamis, Os Draconis, Rhizoma Chuanxiong, Fructus Lycii, Radix Clematidis, eupolyphage sece steleophaga, middle Rhizoma Zingiberis Recens, Borneolum Syntheticum, Sanguis Draxonis, Agkistrodon, this group medicine is selected first-class medical material meticulously, decontamination, clear water is cleaned, dry for standby.Radix Angelicae Sinensis wine is fried, and Olibanum, Myrrha deoil, and Os Draconis, Concha Ostreae fire are forged, and drynaria baronii, the Cortex Eucommiae, Squama Manis are concocted, and Radix Achyranthis Bidentatae, Radix Dipsaci, Radix Clematidis, the Radix Polygoni Multiflori are gently fried, and the Radix Rehmanniae Preparata oven dry adds other drug, wears into smalls (100 order), stirs, and makes capsule.
Drug therapy femur head necrosis of the present invention has good clinical effectiveness.The observation of curative effect of now medicine capsule of the present invention being treated 290 routine femur head necrosiss is summarized as follows:
One, ordinary circumstance
Femur head necrosis person male 188 examples (65%) in 290 examples, women's 102 examples (35%); 45 years old mean age (25～65 years old)
Two, case choice criteria
1, Western medicine diagnose: aseptic necrosis of femoral head.
2, Chinese medical discrimination, kidney qi loss, blockage of main and collateral channels, blood fortune deficiency.
Three, observation index
1, clinical efficacy
2, the improvement of clinical symptoms and sign
3, untoward reaction and toxic action
Four, curative effect judging standard
1, clinical cure: the first phase necrosis, take a month sx, pain is eliminated substantially, and it is convenient to walk.Second phase is downright bad, take one month after, pain relief, after two months, walking freely can be gone up downstairs.The necrosis of three phases serve on 3 months sxs, serve on half a year, functional rehabilitation health.
Five, Therapeutic Method
Oral medicament capsule of the present invention, 3 times on the one, each 2～3 grams, one spoonful of warm water delivery service of Chinese liquor, 1 month is a course of treatment, femur head necrosis basic rehabilitation in 3～6 months.General first phase necrosis needs three courses of treatment of medication, second phase and six courses of treatment of three phases need medication.The taboo maror, the anemia of pregnant woman follows the doctor's advice.
Six, therapeutic outcome
(1) clinical efficacy
1, first phase femur head necrosis clinical cure femur head necrosis person's 88 examples (30.3%) are controlled in examination;
2, second phase, three option share head necrosis clinical cure 110 examples (38%), produce effects 16 examples (5.5%) are controlled in examination; Effective 54 examples (18.6%), invalid 22 examples (7.6%), clinical total effective rate is 92.4%.
(2) clinical symptoms and sign: pain relief, functional rehabilitation are normal substantially.
(3) untoward reaction and toxic and side effects are not all found obvious adverse reaction and toxic and side effects during the medication.
Claims (3)
1, a kind of bone strengthening medicine is characterized in that: be made up of following compatibility of drugs:
Radix Angelicae Sinensis 3～8% Olibanum (processed) 2～8% Radix Achyranthis Bidentataes 2～8%
Radix Notoginseng 2～7% Cortexs Eucommiae 1～5% Radix Rehmanniae Preparata 2～6%
Concha Ostreae 2～8% Pheretimas 1～5% Myrrha (processed) 2～8%
Moschus 0.5～1% Radix Dipsaci 2～6% catechu 1～5%
The Radix Polygoni Multiflori 2～6% Rhizoma Dioscoreaes 2～8% Squama Manis 2～10%
Radix Angelicae Pubescentis 1～6% Stigma Croci 3～10% Os Draconis 2～8%
Rhizoma Chuanxiong 2～8% Fructus Lyciis 2～8% Radix Clematidis 2～8%
Eupolyphage sece steleophaga 5～15% drynaria baroniis 2～8% Borneolum Syntheticums 0.2～1%
Sanguis Draxonis 2～6% Agkistrodons 1～4%
2, a kind of bone strengthening medicine according to claim 1, it is characterized in that: the preferred weight ratio of each percentage composition of above-mentioned raw materials is as follows:
Radix Angelicae Sinensis 4.6% Olibanum (processed) 4% Radix Achyranthis Bidentatae 4%
Radix Notoginseng 4% Cortex Eucommiae 3.6% Radix Rehmanniae Preparata 4.3%
Concha Ostreae 4.3% Pheretima 2.8% Myrrha (processed) 4%
Moschus 0.7% Radix Dipsaci 4% catechu 2.8%
The Radix Polygoni Multiflori 4.3% Rhizoma Dioscoreae 3.6% Squama Manis 4%
Radix Angelicae Pubescentis 2.9% Stigma Croci 5.7% Os Draconis 4.3%
Rhizoma Chuanxiong 4% Fructus Lycii 3.6% Radix Clematidis 4.3%
Eupolyphage sece steleophaga 10% drynaria baronii 4% Borneolum Syntheticum 0.5%
Sanguis Draxonis 4.3% Agkistrodon 1.4%
3, a kind of manufacture method of bone strengthening medicine, it is characterized in that: Radix Angelicae Sinensis, Olibanum (processed), Radix Achyranthis Bidentatae, Radix Notoginseng, the Cortex Eucommiae, Radix Rehmanniae Preparata, Concha Ostreae, Pheretima, Myrrha (processed), Moschus, Radix Dipsaci, catechu, the Radix Polygoni Multiflori, Rhizoma Dioscoreae, Squama Manis, Radix Angelicae Pubescentis, Stigma Croci, Os Draconis, Rhizoma Chuanxiong, Fructus Lycii, Radix Clematidis, eupolyphage sece steleophaga, drynaria baronii, Borneolum Syntheticum, Sanguis Draxonis, Agkistrodon, this group medicine is selected first-class medical material meticulously, decontamination, clear water is cleaned, dry for standby, Radix Angelicae Sinensis wine is fried, Olibanum, Myrrha deoils, Os Draconis, the Concha Ostreae fire is forged, drynaria baronii, the Cortex Eucommiae, Squama Manis is concocted, Radix Achyranthis Bidentatae, Radix Dipsaci, Radix Clematidis, the Radix Polygoni Multiflori is gently fried, and the Radix Rehmanniae Preparata oven dry adds other drug, wears into smalls 100 orders, stir, make capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02130993 CN1435217A (en) | 2002-09-25 | 2002-09-25 | Bone-strengthening medicine and producing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02130993 CN1435217A (en) | 2002-09-25 | 2002-09-25 | Bone-strengthening medicine and producing method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1435217A true CN1435217A (en) | 2003-08-13 |
Family
ID=27628614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02130993 Pending CN1435217A (en) | 2002-09-25 | 2002-09-25 | Bone-strengthening medicine and producing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1435217A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757272B (en) * | 2009-12-23 | 2011-05-25 | 葛孔顺 | Traditional Chinese medicine capsule for treating osteoporosis and degenerative osteoarthritis |
| CN103540505A (en) * | 2013-10-30 | 2014-01-29 | 武汉凌科达科技有限公司 | Preparation method of bone strengthening health care wine |
| CN103555531A (en) * | 2013-10-30 | 2014-02-05 | 武汉凌科达科技有限公司 | Production method of health-care bone-strengthening wine |
-
2002
- 2002-09-25 CN CN 02130993 patent/CN1435217A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757272B (en) * | 2009-12-23 | 2011-05-25 | 葛孔顺 | Traditional Chinese medicine capsule for treating osteoporosis and degenerative osteoarthritis |
| CN103540505A (en) * | 2013-10-30 | 2014-01-29 | 武汉凌科达科技有限公司 | Preparation method of bone strengthening health care wine |
| CN103555531A (en) * | 2013-10-30 | 2014-02-05 | 武汉凌科达科技有限公司 | Production method of health-care bone-strengthening wine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1315197A (en) | Medicine for female acyesis | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
| CN1515290A (en) | Capsule for curing hyperplasia of mammary glands and its preparation method | |
| CN102552520B (en) | Blood circulation-promoting and pain-stopping medicament and preparation process and application thereof | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1435217A (en) | Bone-strengthening medicine and producing method thereof | |
| CN100344318C (en) | Medicine for treating apoplectic sequel and prepn. thereof | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1193772C (en) | Capsule for removing obstruction inchannels to removing blood stasis and its making method | |
| CN1723933A (en) | Traditional Chinese medicine capsule for treating application, and its prodn. method | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN1137713C (en) | Chinese medicine oral preparation for curing apoplectic disease-Suyusan and its preparation method | |
| CN103385963A (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN1319559C (en) | Medicinal composition for treating muscle and bone ache and its preparing process | |
| CN1055002C (en) | External-use cream for treatment of breast cancer | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1186036C (en) | Diabetes treating medicine and its prepn | |
| CN1212132C (en) | Chinese medicine for treating rheumatic diseases and its prepn | |
| CN1176693C (en) | Capsule for treating arthralgia of extremities and its prepn. process | |
| CN1296091C (en) | Chinese traditional medicine composition for treating psoriasis | |
| CN1059115C (en) | Drug composition for curing osteoporosis | |
| CN1117581C (en) | Chinese medicine for treating angina pectonis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |